Estimating cumulative pathway effects on risk for age-related macular degeneration using mixed linear models
暂无分享,去创建一个
Margaret A. Pericak-Vance | William S. Bush | Jonathan L. Haines | Jessica Cooke Bailey | Joshua Hoffman | Jacob B. Hall | William K. Scott | Jaclyn Kovach | Stephen G. Schwartz | Anita Agarwal | Milam Brantley
[1] Susumu Goto,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 2000, Nucleic Acids Res..
[2] A. Ramé. [Age-related macular degeneration]. , 2006, Revue de l'infirmiere.
[3] BMC Bioinformatics , 2005 .
[4] William S Bush,et al. Evidence for polygenic susceptibility to multiple sclerosis--the shape of things to come. , 2010, American journal of human genetics.
[5] R. T. Smith,et al. Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration , 2006, Nature Genetics.
[6] Hiroyuki Ogata,et al. KEGG: Kyoto Encyclopedia of Genes and Genomes , 1999, Nucleic Acids Res..
[7] Benita J. O’Colmain,et al. Prevalence of age-related macular degeneration in the United States. , 2004, Archives of ophthalmology.
[8] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[9] R J Glynn,et al. A prospective study of cigarette smoking and risk of age-related macular degeneration in men. , 1996, JAMA.
[10] P. Zipfel,et al. The role of complement in AMD. , 2010, Advances in experimental medicine and biology.
[11] A E Braley,et al. Dystrophy of the macula. , 1966, American journal of ophthalmology.
[12] N. Orr,et al. Neovascular Age-Related Macular Degeneration Risk Based on CFH, LOC387715/HTRA1, and Smoking , 2007, PLoS medicine.
[13] J L Haines,et al. Association of the apolipoprotein E gene with age-related macular degeneration: possible effect modification by family history, age, and gender. , 2000, Molecular vision.
[14] Jason H. Moore,et al. Pathway analysis of genomic data: concepts, methods, and prospects for future development. , 2012, Trends in genetics : TIG.
[15] P. Jong. Prevalence of age-related macular degeneration in the United States. , 2004 .
[16] Johanna M Seddon,et al. The genetics of age-related macular degeneration: a review of progress to date. , 2006, Survey of ophthalmology.
[17] J. Haines,et al. Genetic Factors in Nonsmokers with Age‐Related Macular Degeneration Revealed Through Genome‐Wide Gene‐Environment Interaction Analysis , 2011, Annals of human genetics.
[18] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[19] E. Agrón,et al. Lutein/zeaxanthin for the treatment of age-related cataract: AREDS2 randomized trial report no. 4. , 2013, JAMA ophthalmology.
[20] Gui-Shuang Ying,et al. The role of apoptosis in age-related macular degeneration. , 2002, Archives of ophthalmology.
[21] William Stafford Noble,et al. Genome-scale mapping of DNase I sensitivity in vivo using tiling DNA microarrays , 2006, Nature Methods.
[22] Gabriëlle H S Buitendijk,et al. Seven New Loci Associated with Age-Related Macular Degeneration , 2013, Nature Genetics.
[23] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[24] J. Heier,et al. Neovascular age-related macular degeneration: individualizing therapy in the era of anti-angiogenic treatments. , 2013, Ophthalmology.
[25] P. Visscher,et al. GCTA: a tool for genome-wide complex trait analysis. , 2011, American journal of human genetics.
[26] P.T.V.M. de Jong,et al. Mechanisms of disease: Age-related macular degeneration , 2006 .
[27] Toshihiro Tanaka. The International HapMap Project , 2003, Nature.
[28] Chen Zhao,et al. mTOR pathway activation in age-related retinal disease , 2011, Aging.
[29] Robert W. Massof,et al. Racial variations in causes of vision loss in nursing homes: The Salisbury Eye Evaluation in Nursing Home Groups (SEEING) Study. , 2004, Archives of ophthalmology.
[30] G. Abecasis,et al. Age-related macular degeneration: genetics and biology coming together. , 2014, Annual review of genomics and human genetics.
[31] Mary Goldman,et al. The UCSC Genome Browser database: update 2011 , 2010, Nucleic Acids Res..
[32] P. Visscher,et al. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.
[33] David Haussler,et al. The UCSC Genome Browser database: update 2010 , 2009, Nucleic Acids Res..
[34] M. Ashburner,et al. Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.
[35] Terrence S. Furey,et al. The UCSC Genome Browser Database: update 2006 , 2005, Nucleic Acids Res..
[36] Johanna M Seddon,et al. The US twin study of age-related macular degeneration: relative roles of genetic and environmental influences. , 2005, Archives of ophthalmology.
[37] Nicolas Leveziel,et al. ARMS2/HTRA1 locus can confer differential susceptibility to the advanced subtypes of age-related macular degeneration. , 2011, American journal of ophthalmology.
[38] Lincoln Stein,et al. Reactome: a knowledgebase of biological pathways , 2004, Nucleic Acids Res..
[39] P. Bernstein,et al. Factorial analysis of tricarboxylic acid cycle intermediates for optimization of zeaxanthin production from Flavobacterium multivorum , 2004, Journal of applied microbiology.
[40] Margaret A. Pericak-Vance,et al. Genetic variants near TIMP3 and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration , 2010, Proceedings of the National Academy of Sciences.
[41] R. Klein,et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. , 2014, The Lancet. Global health.